Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-06-07
1992-06-30
Moezie, F. T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 3, 514 4, 514 21, A61K 3736
Patent
active
051263246
ABSTRACT:
A method is disclosed for enhancing growth of a mammal by administration of a combination of effective amounts of IGF-I and GH so as to enhance the growth of the mammal over the enhancement in growth achieved using either IGF-I or GH alone in an amount equal to that used for either IGF-I or GH, respectively, in the combination. Preferably, the mammal is a child, the IGF-I is native-sequence, mature human IGF-I or human brain IGF-I, and the GH is native-sequence, mature human GH with or without a terminal methionine. In another preferred embodiment, the mammal is a non-human animal of economic importance such as a cow or pig.
REFERENCES:
The Merck Index, 9th ed., Merck & Co. Inc., Rahway, N.J. 1976, p. 7361, entry No. 7360.
Baxter & Martin, Progr. in Growth Factor Res., 1:49-68 (1989).
Roghani et al., FEBS Ltrs., 255(2):253-258 (1989).
Bautista et al., Clin. Res., 38(1):117A (1990).
Ballard et al., Acta Endocr., 121:751-752 (1989).
Lee et al., Mol. Endocr., 2(5):404-411 (1988).
Binkert et al., EMBO J., 8(9):2497-2502 (1989).
Rosenfeld et al., J. Clin. Endocr. & Metab., 70(2):551-553(1990).
Mohan et al., PNAS USA, 86:8338-8342 (1989).
Shimonaka et al., BBRC, 165(1):189-195 (1989).
Pell & Bates, Workshop on Current Trends in Growth Related Research, Haifa, Israel, Oct. 24-27, 1989 (43).
Guler et al., Acta Endocr., 121:456-464 (1989).
Froesch et al., Trends in Endocr. & Metab., 1(5):254-260 (1990).
Moore et al., Endocrin., 122(6):2920-2926 (1988).
Salmon & Daughaday, J. Lab & Clin. Med., 49(6):825-836 (1957).
Guler et al., PNAS, USA, 85:4889-4893 (1988).
Isgaard et al., Am. J. Physiol., 250:E367-E372 (1986).
Ernst & Froesch, BBRC, 151(1):142-147 (1988).
Lobie et al., Endocrin., 126(1):299-306 (1990).
Robinson & Clark, Acta Poediatr Scand (Suppl), 347:93-103 (1988).
Merchau et al., J. Clin. Invest., 81:791-797 (1988).
Schwartz et al., PNAS, USA, 82:8724-8728 (1985).
Lindahl et al., Endocrin., 121(3):1070-1075 (1987).
Cook et al., J. Clin. Invest., 81:206-212 (1988).
Isgaard et al., Endocrin., 123(6):2605-2610 (1988).
Nilsson et al., Calc. Tiss. Int., 40:91-96 (1987).
Otonkoski et al., Diabetes, 37:1678-1683 (1988).
Tippel et al., Pediatric Res., 25(1):76-82 (1989).
Yamashita et al., J. Biol. Chem., 262(27):13254-13257 (1987).
Van Neste et al., J. Endocr., 119:69-74 (1988).
Rosselot et al., The Endocrine Soc. 72.sup.nd Ann. Mtg, Abst., 202 p. 75 (Jun. 1990).
Skottner et al., J. Endocrin., 112:123-132 (1987).
Horikawa et al., Eur. J. Pharmacol., 166:87-94 (1989).
Skottner et al., Endocrin., 124(5):2519-2526 (1989).
Schoenle et al., Acta Endocrinologica, 108:167-174 (1985).
Namba et al., Endocrin., 124(4):1794-1799 (1989).
Young et al., J. Endocrin., 121:563-570 (1989).
Smith et al., J. Orthop. Res., 7:198-207 (1989).
Watanabe et al., J. Endocr., 107:275-283 (1985).
Vetter et al., J. Clin. Invest., 77:1903-1908 (1986).
Schlechter et al., Am. J. Physiol., 250:E231-E235 (1986).
Russell & Spencer, Endocrin., 116(6):2563-2567 (1985).
Orlowski & Chernausek, Endocrin., 123(1):44-49 (1988).
Philips & Vassilopaolou-Sellin, New Engl. J. Med., 302(7):371-380; 438-446 (1980).
Schlechter et al., PNAS, USA, 83:7932-7934 (1986).
Scheiwiller et al., Nature, 323:169-171 (1986).
Phillips & Vassilopoolou-Sellin, New Engl. J. Med., 302(7): 371-380; 438-446 (1980).
Schlechter et al., PNAS, USA, 83: 7932-7934 (1986).
Scheiwiller et al., Nature, 323: 169-171 (1986).
Zezulak & Green, Science, 233: 551-553 (1986).
Madsen et al., Nature, 304: 545-547 (1983).
Tanner et al., Acta, Endocrinologica, 84: 681-696 (1977).
Isaksson et al., Science, 216: 1237-1239 (1982).
Green et al., Differentiation, 29: 195-198 (1985).
Pell & Bates, J. Endocrin., 123 Suppl. #119 (1989).
Clark Ross G.
Cronin Michael J.
Genentech Inc.
Hasak Janet E.
Moezie F. T.
LandOfFree
Method of enhancing growth in patients using combination therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of enhancing growth in patients using combination therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of enhancing growth in patients using combination therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1863805